Search results
Results from the WOW.Com Content Network
ICD 10 code for Encounter for screening for malignant neoplasm of prostate. Get free rules, notes, crosswalks, synonyms, history for ICD-10 code Z12.5.
The ICD-10-CM code to use for annual screening services is Z12.5, Encounter for screening for malignant neoplasm of prostate. Codes in the Z12 category have a “Use additional code” instruction if there is family history of the disease.
Z12.5 is a billable diagnosis code used to specify a medical diagnosis of encounter for screening for malignant neoplasm of prostate. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2024 through September 30, 2025.
Prostate Specific Antigen (PSA), a tumor marker for adenocarcinoma of the prostate, can predict residual tumor in the post-operative phase of prostate cancer. Three to 6 months after radical prostatectomy, PSA is reported to provide a sensitive indicator of persistent disease.
Screening methods for prostate cancer include digital rectal examination (DRE), prostate-specific antigen (PSA) testing, or a combination of both. The code should not be used for diagnostic evaluations or follow-up of confirmed prostate cancer cases. Yes, the Z12.5 code is billable.
The ICD-10 diagnosis code to support either screening is Z12.5 Encounter for screening for malignant neoplasm of prostate. There is no deductible or coinsurance/co-payment for the PSA test, but there is for the screening DRE under Medicare Part B.
Z12.5 is a valid billable ICD-10 diagnosis code for Encounter for screening for malignant neoplasm of prostate. It is found in the 2025 version of the ICD-10 Clinical Modification (CM) and can be used in all HIPAA-covered transactions from Oct 01, 2024 - Sep 30, 2025 .
ICD-10 code Z12.5 for Encounter for screening for malignant neoplasm of prostate is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
Elevated prostate specific antigen [PSA] 2016 2017 - Converted to Parent Code 2018 2019 2020 2021 2022 2023 2024 2025 Non-Billable/Non-Specific Code ICD-10-CM Diagnosis Code Z13.1
Z12.5 is a billable ICD code used to specify a diagnosis of encounter for screening for malignant neoplasm of prostate. A 'billable code' is detailed enough to be used to specify a medical diagnosis.